ClinicalTrials.gg
RecruitingNCT05183152Updated May 1, 2026

Non-invasive BCI-controlled Assistive Devices

An interventional study of NMES Feedback and Visual Feedback in Motor Disorders, Healthy and Spinal Cord Injuries, sponsored by University of Texas at Austin. Recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by University of Texas at Austin · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Jun 2021, registered Dec 2021).
  • Started Jun 2021; still recruiting 5 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Injuries affecting the central nervous system may disrupt the cortical pathways to muscles causing loss of motor control. Nevertheless, the brain still exhibits sensorimotor rhythms (SMRs) during movement intents or motor imagery (MI), which is the mental rehearsal of the kinesthetics of a movement without actually performing it. Brain-computer interfaces (BCIs) can decode SMRs to control assistive devices and promote functional recovery. Despite rapid advancements in non-invasive BCI systems based on EEG, two persistent challenges remain: First, the instability of SMR patterns due to the non-stationarity of neural signals, which may significantly degrade BCI performance over days and hamper the effectiveness of BCI-based rehabilitation. Second, differentiating MI patterns corresponding to fine hand movements of the same limb is still difficult due to the low spatial resolution of EEG. To address the first challenge, subjects usually learn to elicit reliable SMR and improve BCI control through longitudinal training, so a fundamental question is how to accelerate subject training building upon the SMR neurophysiology. In this study, the investigators hypothesize that conditioning the brain with transcutaneous electrical spinal stimulation, which reportedly induces cortical inhibition, would constrain the neural dynamics and promote focal and strong SMR modulations in subsequent MI-based BCI training sessions - leading to accelerated BCI training. To address the second challenge, the investigators hypothesize that neuromuscular electrical stimulation (NMES) applied contingent to the voluntary activation of the primary motor cortex through MI can help differentiate patterns of activity associated with different hand movements of the same limb by consistently recruiting the separate neural pathways associated with each of the movements within a closed-loop BCI setup. The investigators study the neuroplastic changes associated with training with the two stimulation modalities.

02

Conditions studied

  • Motor Disorders
  • Healthy
  • Spinal Cord Injuries
  • Muscular Diseases
  • Motor Neuron Disease
  • Stroke
  • Traumatic Brain Injury
  • Movement Disorders
  • Multiple Sclerosis

Keywords

  • motor deficits
  • able-bodied, healthy
  • unilateral and bilateral stroke
  • spinal cord injury
  • motor neuron diseases
  • muscular diseases (i.e. myopathy)
  • traumatic or neurological pain
  • movement disorders
03

In context

Motor Disorders

73 studies on the registry are indexed under Motor Disorders; 24 are open to participants now.

This study's planned enrollment of 100 is above the median of 41 across 52 interventional studies indexed under Motor Disorders.

Browse Motor Disorders studies →

Lead sponsor

University of Texas at Austin is the lead sponsor of 328 studies on the registry; 79 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Able-bodied participants:

    • good general health
    • normal or corrected vision
    • no history of neurological/psychiatric disease
    • ability to read and understand English (Research Personnel do not speak Spanish)
  2. Subjects with motor disabilities

    • motor deficits due to: unilateral and bilateral stroke / spinal cord injury / motor neuron diseases (i.e. amyotrophic lateral sclerosis, spino-cerebellar ataxia, multiple sclerosis) / muscular diseases (i.e. myopathy) / traumatic or neurological pain / movement disorders (i.e. cerebral palsy) / orthopedic / traumatic brain injury / brain tumors
    • normal or corrected vision
    • ability to read and understand English
    • ability to provide

Exclusion criteria

Exclusion Criteria:

  1. Subjects with motor disabilities

    • short attentional spans or cognitive deficits that prevent the subject from concentrating during the whole experimental session
    • heavy medication affecting the central nervous system (including vigilance)
    • concomitant serious illness (e.g., metabolic disorders)
  2. All participants

    • factors hindering EEG/EMG acquisition and the delivery of non-invasive electrical stimulation (e.g., skin infection, wounds, dermatitis, metal implants under electrodes)
    • criteria identified in safety guidelines for MRI and TMS, in particular metallic implants
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    TESS BCI - Standard MI Task

    Transcutaneous Electrical Spinal Stimulation (TESS) is applied for 20 minutes prior to BCI training sessions. Following TESS, BCI training is performed with visual feedback contingent to motor imagery as detected by a closed-loop BCI.

    Device: Visual Feedback · Device: TESS

  • Active comparator
    Visual BCI - Standard MI Task

    Conventional BCI training is performed with visual feedback contingent to the imagination of right versus left hand movements as detected by a closed-loop BCI.

    Device: Visual Feedback

  • Experimental
    NMES BCI - Difficult MI Task

    BCI training is performed with NMES instead of Visual feedback. NMES is delivered over the flexors/extensors of the forearm contingent to the imagination of same-hand wrist and fingers flexion versus extension as detected by a closed-loop BCI.

    Device: NMES Feedback

  • Active comparator
    Visual BCI - Difficult MI Task

    Conventional BCI training is performed with visual feedback contingent to the imagination of same-hand wrist and fingers flexion versus extension as detected by a closed-loop BCI.

    Device: Visual Feedback

Interventions

  • DeviceNMES Feedback

    Electroencephalography (EEG) signals will be recorded from subjects as they perform cued tasks for flexing/extending their non-dominant hand. The signals will be processed and classified in real-time using machine learning algorithms to trigger electrical stimulation on the flexors/extensors of the targeted arm contingent to the detection of a subject-specific flexion/extension EEG patterns.

  • DeviceVisual Feedback

    Electroencephalography (EEG) - recorded from subjects as they perform cued motor imagery (MI) tasks - are classified in real-time using a subject-specific BCI decoder,. The output classification probability of the decoder is accumulated using exponential smoothing and translated into continuous visual feedback by means of a bar - on a computer screen - that moves to the right or left in response to classification of one or the other MI task.

  • DeviceTESS

    Transcutaneous Electrical Spinal Stimulation (TESS) is applied over the C5-C6 spinal segment for 20 minutes at 30Hz with 5kHz carrier frequency.

06

What researchers measure

Primary outcomes

  1. Change in the BCI command delivery performance

    The command delivery accuracy reflects the level of control of the subject when using the BCI. It measures the percentage of trials in which the subject-specific classifier that is used to differentiate the different imagined movements could accumulate enough evidence to support the presence of EEG patterns specifically associated with the imagined movement in those trials. The score is 0-100, and the higher the value, the better the outcome.

    Time frame: immediately after each intervention session and up to one week after all sessions

  2. Change in the focality and Strength of SMR Modulation

    The focality of sensorimotor rhythm modulation is assessed from EEG using event-related desynchorinzation (ERD) and synchronization (ERS) over the motor area. Continuous measure, the higher the better

    Time frame: immediately after each intervention session and up to one week after all sessions

Secondary outcomes

  1. Stability of Motor Imagery features

    The features corresponding to different motor imagery tasks become more stable at the end of the intervention.

    Time frame: immediately after each intervention session and one-day after all sessions

  2. Separability of Motor Imagery features

    The features corresponding to different motor imagery tasks become more separable after the intervention.

    Time frame: immediately after each intervention session and one-day after all sessions

  3. Changes in motor-evoked potential amplitude

    Continuous measure, the higher the better

    Time frame: immediately after each intervention session and one-day after all sessions

  4. Changes in electroencephalography functional connectivity

    Continuous measure, the more significant changes the better

    Time frame: immediately after each intervention session and one-day after all sessions

  5. Change in focality of fMRI activation for different imagined movements

    The clusters of significant activation during MI of different movements would be more focal in the associated region of the motor area Continuous measure, the more the better.

    Time frame: immediately after each intervention session and one-day after all sessions

  6. More discriminable fMRI activations for different imagined movements

    The activation associated with different MI tasks would be more discriminable from BOLD signals. Continuous measure, the more the better.

    Time frame: immediately after each intervention session and one-day after all sessions

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol

Time frame: All data will be made available by the online publication date

Access criteria: Data will be placed in public servers for any interested researcher to access it

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05183152
Responsible party
Jose del R. Millan (Professor, University of Texas at Austin) — Principal investigator
First posted
Jan 10, 2022
Start date
Jun 16, 2021
Primary completion
Dec 30, 2028 (estimated)
Completion
Dec 30, 2028 (estimated)
Last update
May 1, 2026

Study contacts

Jose del R. Millan, PhD
Contact
jose.millan@austin.utexas.edu
512-232-8111
Hussein Alawieh
Contact
hussein@utexas.edu
512-373-0535
Jose del R. Millan, PhD
principal investigator · The University of Texas at Austin

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion